💨 Abstract
Indian pharmaceutical company Torrent Pharmaceuticals reported a smaller-than-expected Q3 profit due to the closure of its insulin manufacturing facility and currency depreciation in Brazil. Revenue grew 3%, but missed analyst estimates. The company's profit and revenue lagged behind competitors, as rival Granules India and Mankind Pharma also saw lower profits and revenue.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Wang tells Rubio leaders have set tone and direction of US-China ties
Couple stabbed in Delhi park during robbery attempt
Rajasthan BJP chief holds pre-budget discussions
French cyclists on way to Nepal stranded in Bareilly
Wives of alcoholic spouses tie knot with each other in UP's Gorakhpur
2 murder suspects held in Ghaziabad
NHRC notice to Gurugram police chief, discom over 'electrocution' case
JK DGP visits Doda, reviews security situation
Haryana BJP's core group reviews progress of membership campaign
BJP ruined 'health model' of Rajasthan, beds not available for patients in hospitals, says Gehlot
Powered by MessengerX.io